David S. Ritchie
305 Grattan St
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 216 publications
Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation.
Journal: Frontiers in immunology
Published: May 12, 2026
Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: March 13, 2026
Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment.
Journal: Blood neoplasia
Published: February 13, 2026
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring.
Journal: The Journal of antimicrobial chemotherapy
Published: January 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.
Journal: Blood
Published: January 12, 2026
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS.
Journal: Bone marrow transplantation
Published: December 27, 2025
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: December 18, 2025
T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function.
Journal: Frontiers in immunology
Published: November 19, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas.
Journal: Leukemia & lymphoma
Published: November 06, 2025
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies.
Journal: The Lancet. Haematology
Published: October 26, 2025
Last Updated: 09/26/2026